Pfizer Inc.: Breakthroughs that change patients’ lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.pfizer.com. In addition, to learn more, please visit us on www.pfizer.com and follow us on Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Since 2007, Regeneron and Sanofi have collaborated to help people with debilitating and complex conditions that are often difficult to diagnose and treat, using fully-human monoclonal antibodies. Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology.
©2021 Regeneron Pharmaceuticals, Inc., and Sanofi-aventis U.S. LLC. All rights reserved
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world.
Twitter : https://twitter.com/novartisnews
As a vital, complex and fascinating organ, the skin deserves unmatched expertise to ensure continuous improvements in healing and protection. Pierre Fabre Dermatologie is committed to develop and to market therapeutics for dermatology diseases. We focus our research on creating tomorrow’s solutions in pediatric, oncological and rare dermatology diseases. We maintain a close dialogue with dermatologists and other healthcare professionals, and provide them with high quality services such as prescription tools and medical information through scientific reviews. Present in more than 80 countries, our commitment to responding to the needs of physicians and patients is now worldwide.
“Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit our website https://www.lilly.com/
Creating Brighter Futures: By following the science – sometimes into unchartered territory – we continue Lilly’s legacy of delivering innovative medicines that address unmet needs and have a profound and significant impact on people’s lives around the world.”
LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit.
Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions. LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 93 million patients in 130 countries. In 2020, the company generated net sales of DKK 10,133 million.
We as Almirall develop and commercialize high-quality pharmaceuticals, led by our Noble Purpose: “Transform the patients´ world by helping them realize their hopes & dreams for a healthy life."
In several core areas Almirall is striving to enable access to effective and innovative therapeutics for patients with dermatological diseases. These include Psoriasis, Actinic Keratosis, Atopic Dermatitis, Acne and Onychomycosis.
Furthermore, we are offering a broad portfolio of reliable and tested topical therapies for the treatment of various kinds of skin diseases as well as the utilization as concomitant basic therapy.
For decades Almirall has been a reliable partner of dermatologists. We endeavor to fulfill these high aspirations also in the future.
Our Contact Information & Social Media:
Phone: +43 1 595 3960
YouTube channel: https://www.youtube.com/channel/UCntS40DsPAXEoIyufV4xC_g
Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs. Our value chain extends from pre-clinical and clinical development to worldwide marketing and distribution. Biotest manufactures immunoglobulins, clotting factors and albumins which derive from human blood plasma. Biotest currently employs more than 1,900 people worldwide. The most important raw material for our pharmaceuticals is human blood plasma, which we process into effective and highly purified drugs in one of our world leading fractionation facilities in Europe. These medications are used to treat life-threatening diseases such as blood coagulation disorders (haemophilia), severe infections and immune system disorders.
Acne or atopic dermatitis don’t just affect people’s skin. They often also impact their self-esteem and the quality of their lives. With effective, highly tolerable and clinically proven skincare from Eucerin®, people have the chance to make their skin feel better and enjoy life again.
Address for official postal correspondence:
5. kvetna 65, Prague Congress Centre
140 21 Prague 4
1 Place de l'Hôpital
670 91 Strasbourg CEDEX
Office email address
Copyright © 2022 European Society for Pediatric Dermatology